MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33−0.01 (-0.75%)
Close on Nov 18, 2026Market cap $65.46MP/E –Yield –
MediciNova operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MediciNova's operating cash flow for the twelve months ending Jun 30, 2026 was -$9.11M. For fiscal 2025 it was -$9.81M. The highest annual figure on record is $816.53K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.81M | – |
| FY2024 | Dec 31, 2024 | -$10.64M | – |
| FY2023 | Dec 31, 2023 | -$7.43M | – |
| FY2022 | Dec 31, 2022 | -$12.91M | – |
| FY2021 | Dec 31, 2021 | -$9.38M | – |
| FY2020 | Dec 31, 2020 | -$10.83M | – |
| FY2019 | Dec 31, 2019 | -$9.12M | – |
| FY2018 | Dec 31, 2018 | -$9.11M | – |
| FY2017 | Dec 31, 2017 | -$6.92M | – |
| FY2016 | Dec 31, 2016 | -$6.55M | – |
| FY2015 | Dec 31, 2015 | -$7.15M | -975.9% |
| FY2014 | Dec 31, 2014 | $816.53K | – |
| FY2013 | Dec 31, 2013 | -$10.65M | – |
| FY2012 | Dec 31, 2012 | -$11.86M | – |
| FY2011 | Dec 31, 2011 | -$13.31M | – |
| FY2010 | Dec 31, 2010 | -$17.70M | – |
| FY2009 | Dec 31, 2009 | -$17.01M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.47M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.02M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.70M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.78M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.93M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.03M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.81M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$499.06K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.37M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.38M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.18M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.46M | -317.9% |
| Q1 FY2022 | Mar 31, 2022 | -$3.73M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.64M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.02M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.13M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.85M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.95M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.09M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.88M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.04M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.65M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.03M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.64M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.74M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.65M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.08M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.05M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.92M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.41M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.55M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.06M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.58M | – |
See a number that looks wrong?